top of page

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...
JMG Logo transparent.png
Executive Spotlights
Search

Aiolos Bio Launches with $245M Series A Investment

  • Oct 25, 2023
  • 1 min read

San Francisco and London, October 24, 2023 (Business Wire) -- Aiolos Bio, Inc. officially launches as a clinical-stage biopharmaceutical company, committed to addressing unmet medical needs in respiratory and inflammatory conditions. The company secures an oversubscribed $245 million in Series A funding.


Read full article here.

 
 
 

Recent Posts

See All
Qlaris Bio Appoints Fred Guerard as CEO

Dedham, MA, March 1, 2026 (Business Wire) -- Qlaris Bio has appointed Fred Guerard, Pharm.D., as president and chief executive officer, effective March 1, 2026, and he will also join the company’s b

 
 
 

Comments

Life Science Headlines
bottom of page